Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYTARABINE Cause Interstitial lung disease? 143 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 143 reports of Interstitial lung disease have been filed in association with CYTARABINE (cytarabine). This represents 0.3% of all adverse event reports for CYTARABINE.

143
Reports of Interstitial lung disease with CYTARABINE
0.3%
of all CYTARABINE reports
62
Deaths
81
Hospitalizations

How Dangerous Is Interstitial lung disease From CYTARABINE?

Of the 143 reports, 62 (43.4%) resulted in death, 81 (56.6%) required hospitalization, and 22 (15.4%) were considered life-threatening.

Is Interstitial lung disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CYTARABINE. However, 143 reports have been filed with the FAERS database.

What Other Side Effects Does CYTARABINE Cause?

Febrile neutropenia (6,142) Off label use (4,183) Pyrexia (2,992) Neutropenia (2,558) Disease progression (2,352) Drug ineffective (2,281) Thrombocytopenia (2,148) Sepsis (2,013) Myelosuppression (1,869) Product use in unapproved indication (1,619)

What Other Drugs Cause Interstitial lung disease?

METHOTREXATE (3,049) RITUXIMAB (2,458) PEMBROLIZUMAB (2,113) PREDNISONE (1,850) CYCLOPHOSPHAMIDE (1,725) NIVOLUMAB (1,538) AMIODARONE (1,421) DOXORUBICIN (1,352) ETANERCEPT (1,267) ADALIMUMAB (1,250)

Which CYTARABINE Alternatives Have Lower Interstitial lung disease Risk?

CYTARABINE vs CYTARABINE\DAUNORUBICIN CYTARABINE vs DABIGATRAN CYTARABINE vs DABIGATRAN ETEXILATE CYTARABINE vs DABRAFENIB CYTARABINE vs DABRAFENIB\TRAMETINIB

Related Pages

CYTARABINE Full Profile All Interstitial lung disease Reports All Drugs Causing Interstitial lung disease CYTARABINE Demographics